Dr. Makker on Synergy Between Lenvatinib and Pembrolizumab in Endometrial Cancer
2 意见
administrator
09/30/23
Vicky Makker, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the synergy between lenvatinib and pembrolizumab in the treatment of patients with endometrial cancer.
显示更多
脸书评论
没有找到评论